Profilo
Jacqueline Fidanza currently works at Scale Biosciences, Inc., as Chief Operating Officer from 2023.
Posizioni attive di Jacqueline Fidanza
Società | Posizione | Inizio |
---|---|---|
Scale Biosciences, Inc.
Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Scale Biosciences, Inc. is an American single-cell sequencing solutions company that aims to unlock the potential of single-cell analysis at scale by eliminating barriers to discovery. The private company has R & D facilities in Menlo Park, CA and another location that is not specified. The company is located in the US. Scalebio is financed by leading life sciences tools investors Arch Venture Partners, BNG, and Tao Capital. The company's multidisciplinary team of scientists and technologists has combined expertise in next-generation sequencing, genomics, proteomics, and bioinformatics. Discover how their single-cell sequencing technology enables scalable sample indexing, cell throughput, and multi-omics analysis. | Direttore operativo | 01/07/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Scale Biosciences, Inc.
Scale Biosciences, Inc. Medical SpecialtiesHealth Technology Scale Biosciences, Inc. is an American single-cell sequencing solutions company that aims to unlock the potential of single-cell analysis at scale by eliminating barriers to discovery. The private company has R & D facilities in Menlo Park, CA and another location that is not specified. The company is located in the US. Scalebio is financed by leading life sciences tools investors Arch Venture Partners, BNG, and Tao Capital. The company's multidisciplinary team of scientists and technologists has combined expertise in next-generation sequencing, genomics, proteomics, and bioinformatics. Discover how their single-cell sequencing technology enables scalable sample indexing, cell throughput, and multi-omics analysis. | Health Technology |
- Borsa valori
- Insiders
- Jacqueline Fidanza